CDH1 and liver cancer: By analyzing risk assessment using the TCGA-Liver-Cancer patient dataset (422 HCC patient samples) we confirmed that high expression of PD-L1 and mesenchymal marker VIM and low expression of epithelial marker CDH1 genes significantly associated with a high-risk signature (p < 0.05) (Figure 12A).